Company Filing History:
Years Active: 2025
Title: Andriana Inkoom: Innovator in Anticancer Research
Introduction
Andriana Inkoom is a prominent inventor based in Tallahassee, FL (US). She has made significant contributions to the field of cancer research, particularly in developing novel compounds aimed at treating pancreatic cancer. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Andriana holds a patent for "Pyrimidine nucleosides as anticancer agents against pancreatic cancer." This patent presents novel compounds and methods for using these compounds to treat pancreatic cancer. The specific compounds include N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl)octanamide and N-(5-fluoro-2-oxo-1-(tetrahydrofuran-2-yl)-1,2-dihydropyrimidin-4-yl)dodecanamide. These compounds have demonstrated the ability to induce cytotoxicity in pancreatic cancer cells, offering a potential new oral treatment option for this challenging disease. Andriana has 1 patent to her name.
Career Highlights
Andriana is affiliated with Florida A&M University, where she continues her research and development efforts. Her academic background and research focus have positioned her as a key figure in the fight against pancreatic cancer.
Collaborations
Andriana collaborates with esteemed colleagues such as Edward Agyare and Xue You Zhu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Andriana Inkoom's work in developing novel anticancer agents highlights her dedication to improving cancer treatment options. Her innovative research has the potential to make a significant impact on the lives of patients battling pancreatic cancer.